These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 898128)

  • 21. [Action in vitro of isoxsurprine on platelet aggregation induced by ADP, adrenaline and collagen].
    Di Perri T; Forconi S; Vittoria A; Laghi Pasini F; De Gori V
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1385-90. PubMed ID: 4458727
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of furosemide on vitro in platelet aggregation by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1391-6. PubMed ID: 4458728
    [No Abstract]   [Full Text] [Related]  

  • 23. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of ethacrynic acid on vitro in platelet aggregation induced by ADP, adrenaline or collagen].
    Vittoria A; Laghi Pasini F; De Gori V; Forconi S; Di Perri T
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1397-42. PubMed ID: 4458729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanisms of the thrombocytic effects of beta-adrenoblockaders].
    Tumasian KS; Akopov SE; Gabrielian ES
    Farmakol Toksikol; 1988; 51(5):49-53. PubMed ID: 2905276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin and platelet function.
    Zucker MB
    Fed Proc; 1977 Jan; 36(1):47-9. PubMed ID: 318624
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet dysfunction in essential thrombocythaemia.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Ann Clin Res; 1974 Aug; 6(4):198-202. PubMed ID: 4473953
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
    Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
    J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet functions and ultrastructure in the Hermanský-Pudlák syndrome.
    Cieslar P; Hermanský F; Smetana K; Prokes J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(4):553-61. PubMed ID: 4139074
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of storage temperature on the responsiveness of human platelets to agonists.
    Choi JW; Pai SH
    Ann Clin Lab Sci; 2003; 33(1):79-85. PubMed ID: 12661901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet refractoriness to classical agonists in a child with essential thrombocythemia.
    Jaime-Perez JC; Gomez-Almaguer D
    Platelets; 2005 Feb; 16(1):61-2. PubMed ID: 15763898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructure of platelet aggregation in refractory anemia and myelomonocytic leukemia. I. Ultrastructure of aggregation in normal controls and general defects in refractory anemia and myelomonocytic leukemia.
    Pintado T; Maldonado JE
    Mayo Clin Proc; 1976 Jun; 51(6):379-92. PubMed ID: 1063906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Platelet function in the dog].
    Ravera D; Ratto GB; Lunghi C; Armani U; Piana A
    Boll Soc Ital Biol Sper; 1981 Mar; 57(6):698-704. PubMed ID: 7272043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H; Matthias FR; Lasch HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):761-8. PubMed ID: 6083951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human platelets separated from blood by ADP-induced aggregation.
    Mohammad SF; Reddick RL; Mason RG
    Am J Pathol; 1975 Apr; 79(1):81-94. PubMed ID: 1124800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human platelet functions by verapamil.
    Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.